Swarna Securitie (531003)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹51.42 |
| Market Cap | ₹15.43 Cr |
| P/E Ratio | 31.77 |
| ROCE | 16.38% |
| ROE | 18.63% |
| Dividend Yield | 0% |
| Profit Growth | -7.41% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹55.6 — ₹94.92 |
| Sector | Finance |
| Book Value | ₹19.81 |
Strengths
- Historical ROE of 18.63% and ROCE of 16.38% show decent past capital efficiency.
- Positive book value of ₹19.81 per share provides some tangible asset backing.
- Being a listed NBFC gives it a formal regulatory identity and a potential niche in Indian small finance activity.
Concerns
- Latest quarter shows ₹0 crore sales and ₹0 crore net profit, indicating current operations have stalled.
- P/E of 31.77 and P/B of 2.60 are expensive for a company with zero sales growth and declining profits.
- Piotroski F-Score of 3/9 points to weak overall financial health.
- No dividend and no promoter holding disclosure reduce transparency and shareholder friendliness.
AI Analysis
I approach Swarna Securitie as a business, not a trading symbol. It is a micro-cap NBFC with a market capitalisation of just ₹15 crore, so I immediately ask whether it has a durable moat. I do not see one. The latest quarter reveals ₹0 crore in sales and ₹0 crore in net profit. That is a red flag: a lender that cannot generate income in a quarter is not demonstrating economic power. Historical returns are respectable — book value of ₹19.81, return on equity of 18.63%, and ROCE of 16.38% — but those are backward-looking. The more recent profit growth is minus 7.41%, and sales growth is flat at 0%. Meanwhile the price of ₹51.42 means I am paying 31.77 times earnings and 2.60 times book. For a company with no current revenue and no dividend, that valuation offers little margin of safety. The Piotroski F-Score of 3 out of 9 reinforces my concern about financial deterioration. I also cannot evaluate promoter commitment because promoter holding is not disclosed. Some may call this an asset play because book value exists, but at 2.6 times book, I am not buying assets at a discount. I am being asked to pay up for future growth that is not visible in the numbers. In Graham's language, price is what you pay, value is what you get. Here I see no clear stream of future cash flows to justify the price. I would need evidence of renewed lending activity, stable positive profits, and honest disclosure before this becomes a candidate. Until then, this is a pass. I prefer certainty, and this tiny NBFC delivers none.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer